Cargando…
Italian Case Report with a Double Mutation in PSEN1 (K311R and E318G)
Alzheimer’s disease (AD) is the most common cause of dementia worldwide. The clinical spectrum of suspected AD has been extended from mild cognitive impairment (MCI) to preclinical AD which includes people who have typical cognitive function but harbor the underlying biological features of AD. We re...
Autores principales: | Bisceglia, Paola, Lo Vecchio, Filomena, Latino, Raffaela Rita, Gravina, Carolina, Urbano, Maria, la Torre, Annamaria, Desina, Gaetano, Greco, Antonio, Leone, Maurizio, Antonioni, Annibale |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9149895/ https://www.ncbi.nlm.nih.gov/pubmed/35645353 http://dx.doi.org/10.3390/neurolint14020034 |
Ejemplares similares
-
Are apolipoprotein E fragments a promising new therapeutic target for Alzheimer’s disease?
por: Vecchio, Filomena Lo, et al.
Publicado: (2022) -
The PSEN1, p.E318G Variant Increases the Risk of Alzheimer's Disease in APOE-ε4 Carriers
por: Benitez, Bruno A., et al.
Publicado: (2013) -
Patient with PSEN1 Glu318Gly and Other Possible Disease Risk Mutations, Diagnosed with Early Onset Alzheimer’s Disease
por: Yang, YoungSoon, et al.
Publicado: (2023) -
Epigenetic Mechanisms of Aging and Aging-Associated Diseases
por: la Torre, Annamaria, et al.
Publicado: (2023) -
Systematic validation of variants of unknown significance in APP, PSEN1 and PSEN2
por: Hsu, Simon, et al.
Publicado: (2020)